The effect of aortic wall and aortic leaflet stiffening on coronary hemodynamic: a fluid-structure interaction study

S Nobari1, R Mongrain, R Leask

  • 1Department of Biomedical Engineering, McGill University, Montreal, QC, Canada. soroush.nobari@mail.mcgill.ca

Insights

Aortic valve pathologies like aortic sclerosis can affect coronary blood flow. Increased aortic wall or leaflet stiffness and thickness significantly impact coronary flow and shear stress, potentially initiating coronary artery disease.

Area of Science:

  • Cardiovascular research
  • Biomedical engineering
  • Pathophysiology

Background:

  • Aortic valve pathologies, such as aortic sclerosis, are clinically observed to influence coronary blood flow.
  • Simultaneous structural and hemodynamic changes in the aortic valve and coronary arteries are noted in patients with regional aortic valve pathologies.

Purpose of the Study:

  • To investigate the link between local aortic valve pathology and the initiation or progression of coronary artery disease.
  • To elucidate the mechanisms by which aortic valve abnormalities affect coronary hemodynamics.

Main Methods:

  • Computational modeling and simulation of aortic valve and coronary artery interactions.
  • Analysis of the impact of aortic wall and leaflet stiffness and thickness on coronary flow dynamics.

Main Results:

  • Increased aortic wall or leaflet stiffness and thickness significantly alter coronary flow, velocity profiles, and shear stress.
  • A fractional flow reserve cutoff of 0.75 was observed when leaflet thickness and aortic wall stiffness were approximately double and triple normal values, respectively.
  • Observed variations in coronary velocity profiles and wall shear stress suggest a potential pathway for coronary artery disease initiation.

Conclusions:

  • Local aortic valve pathologies can have a considerable impact on coronary hemodynamics.
  • Altered shear stress and flow patterns in coronary arteries due to aortic valve changes may contribute to the development of coronary artery disease.